Brief: Aim Immunotech Inc Entered Into An Equity Distribution Agreement With Maxim Group Llc
19/04/2023 22:16
April 19 (Reuters) - AIM ImmunoTech Inc AIM.A :
* AIM IMMUNOTECH INC - ENTERED INTO AN EQUITY DISTRIBUTION
AGREEMENT WITH MAXIM GROUP LLC
* AIM IMMUNOTECH INC - MAY SELL FROM TIME TO TIME, SHARES OF
COMMON STOCK HAVING AN AGGREGATE OFFERING PRICE OF UP TO $8.5
MILLION
Further company coverage: AIM.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AIM ImmunoTech
See all newsBrief: Aim Immunotech Duripanc Primary Endpoint Analysis To Begin December 2026 Topline Results Expected Q1 2027
Brief: Aim Immunotech Files To Offer And Resell Up To 13.08 Million Shares Of Common Stock By Selling Stockholders
Brief: AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market Under NYSE American Rules
Brief: Aim Immunotech Announces Significant Increase In Stockholder Equity And Extension Of Promissory Note Maturity Date To June 2027
Brief: Aim Immunotech Announces 50% Objective Response Rate (Orr) In Upmc Recurrent Ovarian Cancer Phase 2 Clinical Trial, Suggesting Breakthrough Combination Potential